InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,706.92
(
-0.12%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,127.88
(
0.24%
)
Brent Oil
74.22
(
-0.13%
)
Bitcoin
62,712.52
(
-0.38%
)
Post# of 253167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4547
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: None

Tuesday, 05/17/2022 8:54:09 AM

Tuesday, May 17, 2022 8:54:09 AM

Post# of 253167
AVRO .78 - AVROBIO Reports Positive Data From Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis, Including New Interim Data on Neurocognitive Measures

https://investors.avrobio.com/news-releases/news-release-details/avrobio-reports-positive-data-phase-12-clinical-trial

Any feedback from this board? Good, Bad, Indiffererent?

I own a small position and low-bidding more as one of the cashfat-biobust group.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up